Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment
Max Planck Society · Max Planck Institute of Psychiatry · +7 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
978
total citations
- FWCI
- 9.84
- Percentile
- 100%
- References
- 32
Citations per year
Authors
39- EBElisabeth B. BinderCorresponding
Max Planck Society, Max Planck Institute of Psychiatry
- DSDaria Salyakina
Max Planck Society, Max Planck Institute of Psychiatry
- PLPeter Lichtner
Institute of Groundwater Ecology
- GMGabriele M. Wochnik
Max Planck Society, Max Planck Institute of Psychiatry
- MIMarcus Ising
Max Planck Society, Max Planck Institute of Psychiatry
Topics & keywords
Topics
Keywords
- FKBP5
- Glucocorticoid receptor
- Antidepressant
- Single-nucleotide polymorphism
- Internal medicine
- Biology
- Depression (economics)
- Endocrinology
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.